1. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med, 2004, 350: 2335–2342.
2. Sandler A, Gray R, Perry M, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer. N Engl J Med, 2006, 355: 2542–2550.
3. Miller KD, Sledge GW, Burstein HJ. Angiogenesis inhibition in the treatment of breast cancer: a review of studies presented at the 2006 Sanantonio breast cancer symposium. Clin Adv Hematol Oncol, 2007, 5: 1–12.
4. Cheng QH, Sun SH, Mai XX, et al. Detection and clinical significance of serum vascular endothelial growth factor in patients with malignant tumor. Cancer Res Clin (Chinese), 2005, 17: 180–182.
5. Li JE, Li HL, Lin XR, et al. Relationship of the vascular endothelial growth factor with the recurrent metastasis and prognosis in patients with nasopharyngeal carcinoma. Chin J Clin Rehab (Chinese), 2005, 9: 150–151.